Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.

BACKGROUND Serum metabolites are associated cross-sectionally with kidney function in population-based studies. METHODS Using flow injection and liquid chromatography tandem mass spectrometry methods, we examined longitudinal associations of baseline concentrations of 140 metabolites and their 19 460 ratios with kidney function decline and chronic kidney disease (CKD) incidence over 7 years in 1104 participants of the Cooperative Health Research in the Region of Augsburg S4/F4 study. RESULTS Corrected for multiple testing, a significant association with annual change in the estimated glomerular filtration rate was observed for spermidine (P = 5.8 × 10(-7)) and two metabolite ratios, the phosphatidylcholine diacyl C42:5-to-phosphatidylcholine acyl-alkyl C36:0 ratio (P = 1.5 × 10(-6)) and the kynurenine-to-tryptophan ratio (P = 1.9 × 10(-6)). The kynurenine-to-tryptophan ratio was also associated with significantly higher incidence of CKD at the follow-up visit with an odds ratio of 1.36 per standard deviation increase; 95% confidence interval 1.11-1.66, P = 2.7 × 10(-3)). In separate analyses, the predictive ability of the metabolites was assessed: both the three significantly associated metabolite (ratios) as well as a panel of 35 metabolites selected from all metabolites in an unbiased fashion provided as much but not significantly more prognostic information than selected clinical predictors as judged by the area under the curve. CONCLUSIONS Baseline serum concentrations of spermidine and two metabolite ratios were associated with kidney function change over subsequent years in the general population. In separate analyses, baseline serum metabolites were able to predict incident CKD to a similar but not better extent than selected clinical parameters. Our longitudinal findings provide a basis for targeted studies of certain metabolic pathways, e.g. tryptophan metabolism, and their relation to kidney function decline.

[1]  Raised erythrocyte polyamine levels in non-insulin-dependent diabetes mellitus with great vessel disease and albuminuria. , 1997, Diabetes research and clinical practice.

[2]  Qiong Yang,et al.  Performance of a genetic risk score for CKD stage 3 in the general population. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  J. Stasch,et al.  Kynurenine is an endothelium-derived relaxing factor produced during inflammation , 2010, Nature Medicine.

[4]  H. Volk,et al.  Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  S. Morris,et al.  Arginase-2 Mediates Diabetic Renal Injury , 2011, Diabetes.

[6]  T. Niwa.  Update of uremic toxin research by mass spectrometry. , 2011, Mass spectrometry reviews.

[7]  A. Saito,et al.  Serum levels of polyamines in patients with chronic renal failure. , 1983, Kidney international. Supplement.

[8]  K. Kashiwagi,et al.  Polyamines in renal failure , 2006, Amino Acids.

[9]  E. Schwedhelm,et al.  The role of asymmetric and symmetric dimethylarginines in renal disease , 2011, Nature Reviews Nephrology.

[10]  Christian Gieger,et al.  On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies , 2012, BMC Bioinformatics.

[11]  D. Rothenbacher,et al.  Prevalence of chronic kidney disease in population-based studies: Systematic review , 2008, BMC public health.

[12]  Jerzy Adamski,et al.  Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics , 2011, Metabolomics.

[13]  Nancy R Cook,et al.  Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.

[14]  J. Coresh,et al.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Fabian J Theis,et al.  Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers , 2011, PLoS genetics.

[16]  D. Pawlak,et al.  Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients. , 2010, Advances in medical sciences.

[17]  B. Kestenbaum,et al.  Kidney Function Decline in the Elderly: Impact of Lipoprotein-Associated Phospholipase A2 , 2011, American Journal of Nephrology.

[18]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[19]  C. Gieger,et al.  KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[20]  K. Chida,et al.  Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[21]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[22]  D. Teti,et al.  Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina , 2003, The British journal of ophthalmology.

[23]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[24]  C. Gieger,et al.  Serum metabolite concentrations and decreased GFR in the general population. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  M. Soleimani,et al.  Spermidine/spermine-N¹-acetyltransferase in kidney ischemia reperfusion injury. , 2011, Methods in molecular biology.

[26]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  Yorihiro Yamamoto,et al.  Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry. , 2003, Analytical biochemistry.